| 000 | 01760 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250518044315.0 | ||
| 264 | 0 | _c20200103 | |
| 008 | 202001s 0 0 eng d | ||
| 022 | _a1502-7732 | ||
| 024 | 7 |
_a10.1080/03009742.2019.1600718 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHeslinga, M | |
| 245 | 0 | 0 |
_aSuboptimal cardiovascular risk management in rheumatoid arthritis patients despite an explicit cardiovascular risk screening programme. _h[electronic resource] |
| 260 |
_bScandinavian journal of rheumatology _cSep 2019 |
||
| 300 |
_a345-352 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xcomplications |
| 650 | 0 | 4 |
_aCardiovascular Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xepidemiology |
| 650 | 0 | 4 |
_aCause of Death _xtrends |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aForecasting |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMass Screening _xmethods |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNetherlands _xepidemiology |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRisk Assessment _xmethods |
| 650 | 0 | 4 |
_aRisk Management _xmethods |
| 650 | 0 | 4 |
_aSurvival Rate _xtrends |
| 700 | 1 | _aVan Den Oever, Iam | |
| 700 | 1 | _aJonker, D L | |
| 700 | 1 | _aGriep, E N | |
| 700 | 1 | _aGriep-Wentink, Hrm | |
| 700 | 1 | _aSmulders, Y M | |
| 700 | 1 | _aLems, W F | |
| 700 | 1 | _aBoers, M | |
| 700 | 1 | _aVoskuyl, A E | |
| 700 | 1 | _aPeters, Mjl | |
| 700 | 1 | _aVan Schaardenburg, D | |
| 700 | 1 | _aNurmohamed, M T | |
| 773 | 0 |
_tScandinavian journal of rheumatology _gvol. 48 _gno. 5 _gp. 345-352 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/03009742.2019.1600718 _zAvailable from publisher's website |
| 999 |
_c29809073 _d29809073 |
||